Abstract | BACKGROUND: METHODS: We described nuclear IRS-4 in RKO colon cancer cell lines in biopsies of patients with colorectal cancer (CRC) (n = 20) and in matched adjacent normal colorectal (MANC) tissue (n = 20). RESULTS: Treatment with physiological doses of IGF-1 promoted nuclear influx of IRS-4 from cellular cytosol in RKO cells. When exogenous IRS-4 was overexpressed in RKO cells, there was an increase in cyclin D1, cyclin E, E2F1, pRB Ser 809/811 and pRB Ser 705 levels compared with the empty vector-transfected cells. Some of these changes returned to control values after wortmannin treatment. Subcellular fractionation showed an overexpression of IRS-4 in the cytoplasm, membrane, and nuclei of tumour samples, whereas the levels of the protein were barely detectable in the three compartments of normal samples. Immunohistochemical studies showed positive nuclear IRS-4 staining in over 74% of the tumour cells. IRS-4 was strongly overexpressed in tumoural tissues from CRC patients compared to MANC tissues. The up-regulation of IRS-4 in CRC samples correlated significantly with the increase of several G1 checkpoint proteins including cyclin D1 (r = 0.6662), Rb (r = 0.7779), pRb Serine 809/811 (r = 0.6864), pRb serine 705 (r = 0.6261) and E2F1 (r = 0.8702). CONCLUSIONS: Taken together, our findings suggest that IRS-4 promotes retinoblastoma- cyclin-dependent kinase activation and it may serve as a pharmacological target since its expression is very low in normal tissue, including colonic epithelium.
|
Authors | Patricia Sanmartín-Salinas, María Del Val Toledo Lobo, Fernando Noguerales-Fraguas, Miguel Toro Londoño, Antonio Jiménez-Ruiz, Luis Gonzalez Guijarro |
Journal | Journal of gastroenterology
(J Gastroenterol)
Vol. 53
Issue 8
Pg. 932-944
(Aug 2018)
ISSN: 1435-5922 [Electronic] Japan |
PMID | 29353348
(Publication Type: Journal Article)
|
Chemical References |
- E2F1 Transcription Factor
- E2F1 protein, human
- Insulin Receptor Substrate Proteins
- Proliferating Cell Nuclear Antigen
- Retinoblastoma Protein
- Cyclin D1
- Insulin-Like Growth Factor I
|
Topics |
- Adenocarcinoma
(metabolism)
- Adenoma
(metabolism)
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular
(metabolism)
- Cell Line, Tumor
- Cell Membrane
(metabolism)
- Cell Nucleus
(metabolism)
- Cell Proliferation
(genetics)
- Colon
(metabolism)
- Colorectal Neoplasms
(metabolism, pathology)
- Cyclin D1
(metabolism)
- Cytoplasm
(metabolism)
- E2F1 Transcription Factor
(metabolism)
- Female
- Humans
- Insulin Receptor Substrate Proteins
(genetics, metabolism)
- Insulin-Like Growth Factor I
(pharmacology)
- Liver Neoplasms
(metabolism)
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Staging
- Proliferating Cell Nuclear Antigen
(metabolism)
- Protein Transport
(drug effects)
- Rectum
(metabolism)
- Retinoblastoma Protein
(metabolism)
- Signal Transduction
- Up-Regulation
|